Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Idiopathic Infantile Hypercalcemia

NCT03384121 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT03384121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03384121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Idiopathic Infantile Hypercalcemia
Lead sponsor
The Hospital for Sick Children
Phase
Phase 1
Overall status
Unknown status
Start date
February 22, 2018
Completion date
December 31, 2021
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic infantile hypercalcemia - mild form